These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23204621)

  • 41. Design, synthesis and biological evaluation of antimalarial activity of new derivatives of 2,4,6-s-triazine.
    Pathak M; Ojha H; Tiwari AK; Sharma D; Saini M; Kakkar R
    Chem Cent J; 2017 Dec; 11(1):132. PubMed ID: 29256159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
    Nandi S; Bagchi MC
    Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
    Zahouily M; Lazar M; Elmakssoudi A; Rakik J; Elaychi S; Rayadh A
    J Mol Model; 2006 Mar; 12(4):398-405. PubMed ID: 16341716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of QSAR Equations for Virtual Screening.
    Spiegel J; Senderowitz H
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
    Habibpour E; Ahmadi S
    Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topological and physicochemical characteristics of 1,2,3,4-Tetrahydroacridin- 9(10H)-ones and their antimalarial profiles: a composite insight to the structure-activity relation.
    Sharma BK; Verma S; Prabhakar YS
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):317-35. PubMed ID: 24010931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QSAR Study of
    Santos-Garcia L; de Mecenas Filho MA; Musilek K; Kuca K; Ramalho TC; da Cunha EFF
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30217086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
    Hou X; Chen X; Zhang M; Yan A
    SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QSAR Models for Predicting Aquatic Toxicity of Esters Using Genetic Algorithm-Multiple Linear Regression Methods.
    Rajabi M; Shafiei F
    Comb Chem High Throughput Screen; 2019 Aug; 22(5):317-325. PubMed ID: 31215375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination and prediction of xenoestrogens by recombinant yeast-based assay and QSAR.
    Li F; Chen J; Wang Z; Li J; Qiao X
    Chemosphere; 2009 Mar; 74(9):1152-7. PubMed ID: 19136139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
    Ojha PK; Roy K
    Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The current status of antimalarial drug research with special reference to application of QSAR models.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease.
    Song F; Sun H; Ma X; Wang W; Luan M; Zhai H; Su G; Liu Y
    Front Pharmacol; 2023; 14():1185004. PubMed ID: 37266150
    [No Abstract]   [Full Text] [Related]  

  • 57. Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method.
    Xiao Z; Xiao YD; Feng J; Golbraikh A; Tropsha A; Lee KH
    J Med Chem; 2002 May; 45(11):2294-309. PubMed ID: 12014968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QSAR Study on a Series of Protein Tyrosine Phosphatase 1B Inhibitors.
    Mehta RS; Prajapati HR; Thakkar DV; Brahmkshatriya PS
    Int J Biomed Sci; 2008 Dec; 4(4):266-72. PubMed ID: 23675100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive QSAR modeling for the antioxidant activity of natural compounds derivatives based on Monte Carlo method.
    Ahmadi S; Ghanbari H; Lotfi S; Azimi N
    Mol Divers; 2021 Feb; 25(1):87-97. PubMed ID: 31933105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.